Browse All

Current Filters

CLEAR FILTER x

TITLE

Author Institution:

Early Targeted C1q Inhibition With Tanruprubart Improves Functional Recovery in Guillain-Barré Syndrome: Results From a Phase Three Study

Author:Kroon, Henk-André   Islam, Zhahirul   Navarro, Jose   Kalam Azad, Khan Abul   Morrison, Glenn   Pulkstenis, Erik   Mohammad, Quazi Deen   

Session Name:S21: Neurocritical Care  

Topic:Neurocritical Care  

Program Number:S21.002  

Author Institution:Annexon Biosciences, CA  Laboratory of Gut-Brain Axis, Dhaka, Bangladesh  José R. Reyes Memorial Medical Center, MetroManaila, Philippines  Dhaka Medical College and Hospital, Dhaka, Bangladesh  Annexon Biosciences, Brisbane, CA  National Institute of Neuroscience (NINS), Dhaka, Bangladesh  

Guillain-Barré Syndrome (GBS) is Associated With Substantial Mortality Burden: A U.S. Claims-based Study of Individuals Hospitalized With GBS

Author:Kim, Myoung   Vaghela, Shailja   Murphy, Michael   Turner, Beni   Katsandres, Sarah   Brouwer, Elizabeth   Allen, Jeffrey   

Session Name:P3: Neurocritical Care: Neurosurgery, Spine, and Peripheral Neurology  

Topic:Neurocritical Care  

Program Number:P3.003  

Author Institution:Annexon Biosciences, CA  Magnolia Market Access, NJ  Curta Inc., WA  University of Minnesota, Minneapolis, MN